CFG
ZBH icon

Chapman Financial Group’s Zimmer Biomet ZBH Stock Holding History

Chapman Financial Group’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$188K Sell
2,084
-520
-20% -$47.7K 0.13% 134
2025
Q4 		$234K Hold
2,604
– – 0.16% 120
2025
Q3 		$256K Buy
2,604
+215
+9% +$21.3K 0.18% 113
2025
Q2 		$218K Buy
+2,389
New +$231K 0.18% 95
2024
Q4 		$1.17M Buy
+10,972
New +$1.18M 0.94% 34

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Chapman Financial Group's ZBH Position: Q1 2026 in Review

Chapman Financial Group reduced its Zimmer Biomet (ZBH) stake by 20% in Q1 2026, selling an estimated $47.7K and leaving 2,084 shares worth $188K. The position accounts for 0.13% of the portfolio, ranked #134.

Chapman Financial Group first reported a position in ZBH in Q4 2024 and has held it in 5 quarters since. The position peaked at $1.17M in Q4 2024. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Chapman Financial Group held 2,084 shares of Zimmer Biomet worth $188K as of Q1 2026.
  • Chapman Financial Group sold 520 Zimmer Biomet shares in Q1 2026, an estimated $47.7K.
  • Zimmer Biomet made up 0.13% of Chapman Financial Group's portfolio in Q1 2026, its #134 holding.
  • Chapman Financial Group first reported a position in Zimmer Biomet in Q4 2024 and has held it in 5 quarters since.
  • Chapman Financial Group's Zimmer Biomet position peaked at $1.17M in Q4 2024.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Chapman Financial Group's 13F filing for Q1 2026, filed 12 May 2026.